Sorafenib plus chemotherapy versus chemotherapy alone in advanced pancreatic cancer: A randomized phase II trial.

Stefano Cascinu,Rossana Berardi,A. Sobrero,R. Labianca,Paolo Bidoli,S. Siena,D. Ferraris,S. Barni,R. Cengarle,Marta Monteforte

Sorafenib plus chemotherapy versus chemotherapy alone in advanced pancreatic cancer: A randomized phase II trial.

2010

Stefano Cascinu
Rossana Berardi
A. Sobrero
R. Labianca
Paolo Bidoli
S. Siena
D. Ferraris
S. Barni
R. Cengarle
Marta Monteforte

4066 Background: No standard treatment is available for advanced pancreatic cancer (PC). Although gemcitabine is used with the purpose of symptom palliation, there is no clear evidence of a signifi...

Keywords:

Physical therapy
Pancreatic cancer
Cancer research
Oncology
Sorafenib
Internal medicine
Chemotherapy
Medicine
Standard treatment
Gemcitabine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations